CD38 prognostic role in chronic lymphocytic leukemia patients treated with standard chemotherapy or targeted agents: a monocentric real-life experience
In conclusion, CD38 expression emerges as a key prognostic marker in CLL, reinforcing the need to integrate clinical, biological, phenotypic, and molecular factors into treatment decision-making and both standard chemotherapy and targeted regimens remain effective in real-life settings.
Authors
- Carmine Selleri (ORCID: https://orcid.org/0000-0002-5861-8984)
- Raffaele Fontana (ORCID: https://orcid.org/0009-0000-3990-120X)
- Maria Teresa Buonanno
- Valentina Giudice (ORCID: https://orcid.org/0000-0002-7492-6848)
- Roberto Guariglia (ORCID: https://orcid.org/0009-0009-4165-8646)
- Luca Pezzullo (ORCID: https://orcid.org/0000-0001-6867-7331)
- Idalucia Ferrara (ORCID: https://orcid.org/0009-0006-2778-8127)
- Rossella Marcucci (ORCID: https://orcid.org/0000-0001-9549-7176)
- Serena Luponio (ORCID: https://orcid.org/0009-0002-7063-970X)
- Anna Maria Della Corte (ORCID: https://orcid.org/0009-0000-1972-6336)
- Laura Mettivier (ORCID: https://orcid.org/0000-0003-1473-7487)
- Bianca Serio (ORCID: https://orcid.org/0000-0001-6613-2370)
- Danilo De Novellis (ORCID: https://orcid.org/0000-0002-2590-0529)
- Maria Carmen Martorelli
Institutions
- University of Salerno (IT)
- Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona (IT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.3389/fonc.2025.1569707
- Citations
- 1
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- Università degli Studi di Salerno